Literature DB >> 9020477

A detailed analysis of the role of K-ras gene mutation in the progression of colorectal adenoma.

T Ohnishi1, N Tomita, T Monden, M Ohue, I Yana, K Takami, H Yamamoto, T Yagyu, N Kikkawa, T Shimano, M Monden.   

Abstract

To elucidate the role of ras gene mutations during the early stage of colorectal tumour progression, K-ras gene mutations were analysed in 32 benign adenomas and 36 adenomas with focal carcinoma in the colorectum by microscraping of histologically pure regions from tissue sections, polymerase chain reaction-restriction fragment length polymorphism and in part by direct sequencing. Several regions were scraped out and analysed when an adenoma contained areas with different grades of dysplasia. The frequencies of K-ras gene mutation in mild dysplasia, moderate dysplasia and focal carcinoma were 19% (7/36), 51% (25/49) and 39% (14/36) respectively. The K-ras gene status was heterogeneous in 4 of the 11 benign adenomas from which multiple samples were obtained, and mutations were always found in the regions with more advanced dysplasia in these adenomas. Thirteen of the 36 adenomas with focal carcinoma showed heterogeneity of mutations between the adenoma region and the focal carcinoma. Seven of which had mutations only in the adenoma region. These findings indicated that the K-ras gene mutations occur during the late stage of adenoma progression and may confer a more advanced morphological phenotype of adenoma, but these mutations are not mainly involved in malignant transformation from adenoma to carcinoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020477      PMCID: PMC2063378          DOI: 10.1038/bjc.1997.56

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Occurrence of Ki-ras and p53 mutations in primary colorectal tumors.

Authors:  P Shaw; S Tardy; E Benito; A Obrador; J Costa
Journal:  Oncogene       Date:  1991-11       Impact factor: 9.867

2.  Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers.

Authors:  K W Kinzler; M C Nilbert; B Vogelstein; T M Bryan; D B Levy; K J Smith; A C Preisinger; S R Hamilton; P Hedge; A Markham
Journal:  Science       Date:  1991-03-15       Impact factor: 47.728

3.  Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma.

Authors:  Y Kawasaki; T Monden; H Morimoto; M Murotani; Y Miyoshi; T Kobayashi; T Shimano; T Mori
Journal:  Am J Clin Pathol       Date:  1992-02       Impact factor: 2.493

4.  Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.

Authors:  W Jiang; S M Kahn; J G Guillem; S H Lu; I B Weinstein
Journal:  Oncogene       Date:  1989-07       Impact factor: 9.867

5.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

6.  Altered growth of human colon cancer cell lines disrupted at activated Ki-ras.

Authors:  S Shirasawa; M Furuse; N Yokoyama; T Sasazuki
Journal:  Science       Date:  1993-04-02       Impact factor: 47.728

7.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.

Authors:  I Nishisho; Y Nakamura; Y Miyoshi; Y Miki; H Ando; A Horii; K Koyama; J Utsunomiya; S Baba; P Hedge
Journal:  Science       Date:  1991-08-09       Impact factor: 47.728

8.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

9.  Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.

Authors:  P W Hinds; C A Finlay; R S Quartin; S J Baker; E R Fearon; B Vogelstein; A J Levine
Journal:  Cell Growth Differ       Date:  1990-12

10.  Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer.

Authors:  S M Bell; N Scott; D Cross; P Sagar; F A Lewis; G E Blair; G R Taylor; M F Dixon; P Quirke
Journal:  Gastroenterology       Date:  1993-01       Impact factor: 22.682

View more
  16 in total

1.  Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.

Authors:  Janine G Einspahr; Maria Elena Martinez; Ruiyun Jiang; Chiu-Hsieh Hsu; Asif Rashid; Achyut K Bhattacharrya; Dennis J Ahnen; Elizabeth T Jacobs; P Scott Houlihan; C Renee Webb; David S Alberts; Stanley R Hamilton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

Review 2.  Regulation of homeostasis and oncogenesis in the intestinal epithelium by Ras.

Authors:  Sergia Velho; Kevin M Haigis
Journal:  Exp Cell Res       Date:  2011-06-17       Impact factor: 3.905

3.  Iro/IRX transcription factors negatively regulate Dpp/TGF-β pathway activity during intestinal tumorigenesis.

Authors:  Òscar Martorell; Francisco M Barriga; Anna Merlos-Suárez; Camille Stephan-Otto Attolini; Jordi Casanova; Eduard Batlle; Elena Sancho; Andreu Casali
Journal:  EMBO Rep       Date:  2014-10-08       Impact factor: 8.807

4.  No major difference in K-ras and p53 abnormalities in sporadic and hereditary nonpolyposis colorectal adenomas.

Authors:  D W Voskuil; E Kampman; W van Geloof; M Grubben; F Kok; G van Muijen; F Nagengast; H Vasen; P van't Veer
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

5.  Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.

Authors:  Feijun Luo; David G Brooks; Hongtao Ye; Rifat Hamoudi; George Poulogiannis; Charles E Patek; Douglas J Winton; Mark J Arends
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

6.  KRAS gene mutations are more common in colorectal villous adenomas and in situ carcinomas than in carcinomas.

Authors:  Peter Zauber; Stephen Marotta; Marlene Sabbath-Solitare
Journal:  Int J Mol Epidemiol Genet       Date:  2013-03-18

Review 7.  The advent of precision therapy in gastrointestinal malignancies: Targeting the human epidermal growth factor receptor family in colorectal and esophagogastric cancer.

Authors:  Danielle Desautels; Craig Harlos; Piotr Czaykowski
Journal:  J Carcinog       Date:  2014-11-27

8.  Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions.

Authors:  Chenghao Yi; Yanqing Huang; Xing Yu; Xiaofen Li; Shu Zheng; Kefeng Ding; Jinghong Xu
Journal:  Oncotarget       Date:  2016-03-29

9.  Oncogene Mutations in Colorectal Polyps Identified in the Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study.

Authors:  Jon A Lorentzen; Krzysztof Grzyb; Paula M De Angelis; Geir Hoff; Tor J Eide; Per Arne Andresen
Journal:  Clin Med Insights Pathol       Date:  2016-09-07

10.  Conserved mechanisms of tumorigenesis in the Drosophila adult midgut.

Authors:  Òscar Martorell; Anna Merlos-Suárez; Kyra Campbell; Francisco M Barriga; Christo P Christov; Irene Miguel-Aliaga; Eduard Batlle; Jordi Casanova; Andreu Casali
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.